Catalent Pharma Solutions’ Post

Discover advanced GMP-compatible procedures that ensure simplified, robust, and scalable workflows. Dive into the evolution of protocols for generating clinically relevant cell types from induced pluripotent stem cells (iPSCs). #iPSCells #StemCellResearch #GMP #Biotech #CellTherapy https://ow.ly/nhFj50Syc3C

Discover advanced GMP-compatible procedures that ensure simplified, robust, and scalable workflows. Dive into the evolution of protocols for generating clinically relevant cell types from induced pluripotent stem cells (iPSCs). #iPSCells #StemCellResearch #GMP #Biotech #CellTherapy https://ow.ly/G5FC50Spl4A

It's an incredibly exciting time in the world of pluripotent stem cell (PSC) research and manufacturing. These advances are, of course, essential to the future of PSC applications across the fields of drug discovery and development, cellular therapeutics, personalized medicine, and beyond. "Pluripotent stem cell banking with a closed, automated, and GMP-compliant system": Establishment of PSC banks, including master cell banks and working cell banks, by expanding cells in a GMP-compliant environment is a vital step during the manufacturing processes of PSC-based cell therapies. The CliniMACS Prodigy Adherent Cell Culture process offers nine modules representing different workflow steps, such as coating, inoculation, culture, media change, and harvest, during cell manufacturing. These modules can be flexibly combined to automate the PSC expansion process while the GMP-compliant, single-use CliniMACS Prodigy Tubing Set 730 provides a closed and sterile environment for PSC cultures. External culture vessels can also easily be connected to extend manufacturing scalability, highlighting the CliniMACS Prodigy as a ready-to-use solution for GMP-compliant PSC banking. Learn more at: https://lnkd.in/g4K_ZwNV #cellculture #cellmanufacturing #stemcells #ipscells Miltenyi Biotec Friederike Fassbender Isabelle Haake

Discover advanced GMP-compatible procedures that ensure simplified, robust, and scalable workflows. Dive into the evolution of protocols for generating clinically relevant cell types from induced pluripotent stem cells (iPSCs). #iPSCells #StemCellResearch #GMP #Biotech #CellTherapy https://ow.ly/G5FC50Spl4A

Discover advanced GMP-compatible procedures that ensure simplified, robust, and scalable workflows. Dive into the evolution of protocols for generating clinically relevant cell types from induced pluripotent stem cells (iPSCs). #iPSCells #StemCellResearch #GMP #Biotech #CellTherapy https://ow.ly/Toq350SwXIk

Discover advanced GMP-compatible procedures that ensure simplified, robust, and scalable workflows. Dive into the evolution of protocols for generating clinically relevant cell types from induced pluripotent stem cells (iPSCs). #iPSCells #StemCellResearch #GMP #Biotech #CellTherapy https://ow.ly/Toq350SwXIk

It's #BuzzTechTuesday! Check out this Georgia Institute of Technology microfluidic innovation that quickly and efficiently separates intact cell colonies for selective isolation and purification of stem cells for research and regenerative therapeutics. Learn more about it! #hipsc #microfluidics #regenerativetherapies #stemcells https://ow.ly/INiE50RTYCo

Explore the Transformative Potential of Mesenchymal Stem Cells (MSCs) in Therapeutic Development! At REPROCELL, we're committed to enabling groundbreaking research by providing MSCs to revolutionize drug discovery. Learn how MSCs offer insights into drug effects, aid in tissue repair, and hold promise for treating a range of medical conditions. Discover more in our new blog: https://hubs.li/Q02yvDMh0 #MSCs

It's an incredibly exciting time in the world of pluripotent stem cell (PSC) research and manufacturing. These advances are, of course, essential to the future of PSC applications across the fields of drug discovery and development, cellular therapeutics, personalized medicine, and beyond. "Pluripotent stem cell banking with a closed, automated, and GMP-compliant system": Establishment of PSC banks, including master cell banks and working cell banks, by expanding cells in a GMP-compliant environment is a vital step during the manufacturing processes of PSC-based cell therapies. The CliniMACS Prodigy Adherent Cell Culture process offers nine modules representing different workflow steps, such as coating, inoculation, culture, media change, and harvest, during cell manufacturing. These modules can be flexibly combined to automate the PSC expansion process while the GMP-compliant, single-use CliniMACS Prodigy Tubing Set 730 provides a closed and sterile environment for PSC cultures. External culture vessels can also easily be connected to extend manufacturing scalability, highlighting the CliniMACS Prodigy as a ready-to-use solution for GMP-compliant PSC banking. Learn more at: https://lnkd.in/g4K_ZwNV #cellculture #cellmanufacturing #stemcells #ipscells Miltenyi Biotec Friederike Fassbender Isabelle Haake

Do you want to expand and differentiate human pluripotent stem cells (PSCs) into cardiomyocytes with minimal hands-on time? Our CliniMACS Prodigy® Adherent Cell Culture enables you to accomplish exactly this – in a closed system with a high degree of automation. This not only helps you to save precious time, but also minimizes open handling steps and thereby protects your valuable cells. The process includes nine modules representing different workflow steps such as coating, inoculation, media change, cell passaging, and harvesting. This smart modularization allows you to adjust the process to your protocol easily. Take your manufacturing of PSC-derived cardiomyocytes to the next level! ℹ️ More info: https://lnkd.in/gq86s4YC 📝 Application Note:  https://lnkd.in/g27SB5v5 For more inquiries, kindly contact marketing@canvio.net or 010-260 7228. #miltenyibiotec